Resources

The Cognex In-Sight 5000 Series is obsolete, but replacing it involves much more than swapping cameras. Discover the five key questions every manufacturer should answer before upgrading their machine vision system.

Discover how self-healing AI is reshaping regulated manufacturing. By continuously adapting, retraining, and staying compliant, it turns production into a smarter, more resilient, and audit-ready process—paving the way for the Factory of the Future.

The EU AI Act is reshaping how artificial intelligence is developed and deployed across regulated industries. Discover what pharmaceutical manufacturers need to know about AI-powered inspection, including validation, transparency, traceability and maintaining GMP compliance.

Modern digital manufacturing starts with connected systems. Explore how life sciences manufacturers are integrating legacy infrastructure with modern digital operations to improve visibility, efficiency, and compliance.

The standard operating procedure (SOP) for line clearance is frequently scrutinized because it represents a primary control against cross-contamination and mislabeling. 

The requirement for rigorous safety checks often creates a tension between the need for speed and the necessity of quality. 

Many manufacturers rely on manual visual inspections by operators, this approach carries significant financial and operational risks that are not always immediately visible on a balance sheet.

As production environments become more complex traditional paper-based SOPs for line clearance often fall short of their intended goal due to their static nature. 

Maintaining compliance during line clearance is not just a matter of operational preference but a legal requirement that determines a facility's right to operate.

As production speeds increase and regulatory requirements become more stringent, the limitations of manual inspection are becoming more apparent

In this third instalment of our Ask the Expert series, Mike explains how Catalyx keeps delivery tightly aligned with client KPIs, ensuring that every action drives tangible, data-backed outcomes.

This is Part 2 of our three-part ‘Ask the Expert’ series with Mike, Director of Sales and Delivery at Catalyx, where we uncover what makes their non-conventional outsourcing models so effective in the pharmaceutical industry.